Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DGX Quest Diagnostics	$178.74 -0.2%	$174.48	$146.17 ▼ $182.38	$19.98B	0.46	1.17 million shs	350,768 shs
DVA DaVita	$134.45 -0.2%	$139.80	$126.07 ▼ $179.60	$9.62B	1.09	866,068 shs	264,205 shs
IPCM (IPCM)		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	N/A
LH Labcorp	$272.10 -0.2%	$258.82	$209.38 ▼ $283.47	$22.61B	0.78	724,631 shs	125,502 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DGX Quest Diagnostics	+0.20%	+3.45%	+6.32%	+1.51%	+18.71%
DVA DaVita	+1.91%	+4.90%	-6.15%	-6.18%	-7.71%
LH Labcorp	+1.25%	+4.39%	+9.11%	+10.70%	+21.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DGX Quest Diagnostics	4.581 of 5 stars	1.3	2.0	4.2	4.7	3.5	2.5	2.5
DVA DaVita	4.2964 of 5 stars	2.0	1.0	0.0	4.5	2.1	2.5	3.8
IPCM (IPCM)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LH Labcorp	4.7639 of 5 stars	2.3	5.0	2.5	4.2	3.0	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DGX Quest Diagnostics	2.67	Moderate Buy	$186.00	4.06% Upside
DVA DaVita	2.00	Hold	$164.00	21.97% Upside
IPCM (IPCM)	0.00	N/A	N/A	N/A
LH Labcorp	2.62	Moderate Buy	$289.58	6.42% Upside

Current Analyst Ratings Breakdown

Latest IPCM, LH, DGX, and DVA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	DVA DaVita	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$148.00
8/7/2025	DVA DaVita	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$169.00 ➝ $160.00
7/25/2025	LH Labcorp	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$282.00 ➝ $305.00
7/25/2025	LH Labcorp	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$290.00 ➝ $310.00
7/25/2025	LH Labcorp	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$285.00 ➝ $300.00
7/25/2025	LH Labcorp	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$283.00 ➝ $306.00
7/25/2025	LH Labcorp	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$290.00 ➝ $302.00
7/23/2025	DGX Quest Diagnostics	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$185.00
7/23/2025	DGX Quest Diagnostics	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
7/23/2025	DGX Quest Diagnostics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$190.00 ➝ $192.00
7/23/2025	DGX Quest Diagnostics	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$160.00 ➝ $178.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DGX Quest Diagnostics	$9.87B	2.02	$13.51 per share	13.23	$64.97 per share	2.75
DVA DaVita	$12.82B	0.75	$19.49 per share	6.90	($1.51) per share	-89.04
IPCM (IPCM)	N/A	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$13.01B	1.74	$22.64 per share	12.02	$101.96 per share	2.67

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DGX Quest Diagnostics	$871M	$8.35	21.40	17.04	2.37	9.01%	15.24%	6.64%	10/28/2025 (Estimated)
DVA DaVita	$936.34M	$10.17	13.22	10.58	0.95	6.35%	369.39%	4.62%	N/A
IPCM (IPCM)	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$746M	$9.06	30.03	15.51	1.72	5.66%	15.45%	7.02%	10/23/2025 (Estimated)

Latest IPCM, LH, DGX, and DVA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2025	Q2 2025	DVA DaVita	$2.70	$2.95	+$0.25	$2.58	$3.36 billion	$3.38 billion
7/24/2025	Q2 2025	LH Labcorp	$4.14	$4.35	+$0.21	$2.84	$3.49 billion	$3.53 billion
7/22/2025	Q2 2025	DGX Quest Diagnostics	$2.57	$2.62	+$0.05	$2.47	$2.73 billion	$2.76 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DGX Quest Diagnostics	$3.20	1.79%	N/A	38.32%	14 Years
DVA DaVita	N/A	N/A	N/A	N/A	N/A
IPCM (IPCM)	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	1.06%	N/A	31.79%	N/A

Latest IPCM, LH, DGX, and DVA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/13/2025	DGX Quest Diagnostics	quarterly	$0.80	1.79%		10/3/2025	10/20/2025
7/10/2025	LH Labcorp	quarterly	$0.72	1.11%		8/28/2025	9/11/2025
5/14/2025	DGX Quest Diagnostics	quarterly	$0.80	1.86%	7/7/2025	7/7/2025	7/21/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DGX Quest Diagnostics	0.71	1.09	0.99
DVA DaVita	23.18	1.39	1.34
IPCM (IPCM)	N/A	N/A	N/A
LH Labcorp	0.61	1.50	1.32

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DGX Quest Diagnostics	88.06%
DVA DaVita	90.12%
IPCM (IPCM)	N/A
LH Labcorp	95.94%

Insider Ownership

Company	Insider Ownership
DGX Quest Diagnostics	8.16%
DVA DaVita	1.50%
IPCM (IPCM)	N/A
LH Labcorp	0.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DGX Quest Diagnostics	56,000	111.82 million	102.70 million	Optionable
DVA DaVita	76,000	71.50 million	70.43 million	Optionable
IPCM (IPCM)	N/A	N/A	N/A	Not Optionable
LH Labcorp	70,000	83.10 million	82.40 million	Optionable

IPCM, LH, DGX, and DVA Headlines

Recent News About These Companies

Virtu Financial LLC Takes $702,000 Position in Labcorp Holdings Inc. (NYSE:LH)

August 14 at 4:53 AM | marketbeat.com

JPMorgan Chase & Co. Decreases Holdings in Labcorp Holdings Inc. (NYSE:LH)

August 14 at 4:34 AM | marketbeat.com

Citigroup Inc. Has $21.46 Million Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)

August 14 at 4:24 AM | marketbeat.com

1 Mooning Stock Worth Investigating and 2 Facing Challenges

August 13 at 9:01 AM | msn.com

Labcorp Holdings Inc. (NYSE:LH) Shares Bought by Westpac Banking Corp

August 13 at 6:46 AM | marketbeat.com

Invesco Ltd. Purchases 318,865 Shares of Labcorp Holdings Inc. (NYSE:LH)

August 13 at 4:49 AM | marketbeat.com

Mizuho Securities USA LLC Sells 1,249 Shares of Labcorp Holdings Inc. (NYSE:LH)

August 13 at 4:49 AM | marketbeat.com

1 Safe-and-Steady Stock to Target This Week and 2 We Find Risky

August 12 at 5:58 PM | msn.com

CCM Investment Group LLC Takes Position in Labcorp Holdings Inc. (NYSE:LH)

August 12 at 6:24 AM | marketbeat.com

Labcorp Holdings Inc. (NYSE:LH) Shares Purchased by Forsta AP Fonden

August 12 at 4:53 AM | marketbeat.com

Labcorp Holdings Inc. (NYSE:LH) Shares Sold by Swiss National Bank

August 12 at 4:34 AM | marketbeat.com

Deutsche Bank AG Sells 21,687 Shares of Labcorp Holdings Inc. (NYSE:LH)

August 12 at 4:14 AM | marketbeat.com

Charles Schwab Investment Management Inc. Has $147.74 Million Stock Position in Labcorp Holdings Inc. (NYSE:LH)

August 12 at 4:13 AM | marketbeat.com

Labcorp Holdings Inc. (NYSE:LH) Shares Sold by Barnett & Company Inc.

August 11 at 7:42 AM | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Acquires 13,620 Shares of Labcorp Holdings Inc. (NYSE:LH)

August 11 at 6:21 AM | marketbeat.com

ASR Vermogensbeheer N.V. Invests $650,000 in Labcorp Holdings Inc. (NYSE:LH)

August 11 at 6:03 AM | marketbeat.com

Labcorp Holdings Inc. (NYSE:LH) Shares Purchased by Vanguard Group Inc.

August 11 at 5:55 AM | marketbeat.com

Statutory Profit Doesn't Reflect How Good Labcorp Holdings' (NYSE:LH) Earnings Are

August 9, 2025 | finance.yahoo.com

Labcorp Holdings Inc. (NYSE:LH) Stake Decreased by LPL Financial LLC

August 9, 2025 | marketbeat.com

Jensen Investment Management Inc. Sells 8,070 Shares of Labcorp Holdings Inc. (NYSE:LH)

August 7, 2025 | marketbeat.com

AXS Investments LLC Grows Position in Labcorp Holdings Inc. (NYSE:LH)

August 7, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IPCM, LH, DGX, and DVA Company Descriptions

Quest Diagnostics NYSE:DGX

$178.74 -0.31 (-0.17%)

As of 03:21 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

DaVita NYSE:DVA

$134.45 -0.24 (-0.18%)

As of 03:20 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

(IPCM) NASDAQ:IPCM

IPC Healthcare, Inc., formerly IPC The Hospitalist Company, Inc., is a national acute hospitalist and post-acute provider group practice in the United States. The Company's clinical services are focused on providing, managing and coordinating the care of hospitalized patients and serving as the inpatient partner of primary care physicians and specialists. The Company provides its affiliated clinicians with administrative and professional services to support their practice of medicine. Each of the Company's operating regions is led by an executive director and team of marketing and administrative staff that is responsible for strategic planning, coordinating with its national staff to recruit clinicians, managing hospital and post-acute care facilities, and payor relationships and contracts, among others. In addition, the Company serves business and government organizations, and healthcare and educational institutions with its Intelligent Technology solutions.

Labcorp NYSE:LH

$272.10 -0.44 (-0.16%)

As of 03:21 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time